Synotic

Quick links to important sections

Synotic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Synotic

Property Description
Active Ingredients Fluocinolone Acetonide, Dimethyl Sulfoxide (DMSO)
Form Otic Solution (Liquid)
Pharmacological Class Topical Corticosteroid & Penetration Enhancer
General Purpose Anti-inflammation and Pruritus Relief
Origin Synthetic (Glucocorticoid Derivative)

Synotic is a specialized, prescription-only combination veterinary drug formulated as a clear otic solution for administration into the ear canal of dogs. Its distinctive feature is the pairing of a potent topical corticosteroid with a highly effective penetration enhancer, a formulation strategy designed to deliver concentrated relief. It is primarily utilized for its anti-inflammatory action and pruritus relief.


What Type of Combination Medication is Synotic?

Synotic is an anti-inflammatory agent that merges two complementary actions to address localized ear conditions. This medication is a synthetic dual-active product, combining a component to suppress inflammation with a component to enhance drug delivery. The primary active steroid, Fluocinolone Acetonide, is classified as a potent glucocorticoid derivative, a pharmacological class used for suppressing inflammatory processes. This classification underscores its approach: combining inflammation suppression with enhanced absorption for a local therapeutic effect.


Composition and The Unique Role of Dimethyl Sulfoxide (DMSO)

The formulation is defined by its two principal active ingredients: Fluocinolone Acetonide and Dimethyl Sulfoxide (DMSO), with Propylene Glycol serving as a primary vehicle. The essential component that differentiates this product is the high concentration of Dimethyl Sulfoxide, which acts as a powerful penetration enhancer. This component increases the transdermal absorption of other compounds. This delivery mechanism is the defining characteristic of the Synotic formulation, ensuring the therapeutic agent reaches the affected ear tissues.


General Purpose: Addressing Inflammation and Pruritus

The general therapeutic purpose of this medication is to reduce the inflammation and alleviate the pruritus (itching) associated with various ear irritations. By leveraging the anti-inflammatory effect of the corticosteroid alongside the tissue-penetrating ability of the DMSO, the medication targets the underlying causes of tissue irritation and discomfort. This combined approach is designed to provide focused symptomatic relief at the site of the ear canal pathology.

Regulatory References

  1. Glucocorticoids: Mechanisms of Action

What side effects are possible with Synotic?

The official regulatory labeling documents specific safety characteristics for the otic solution (Fluocinolone Acetonide and Dimethyl Sulfoxide), outlining potential localized and systemic adverse effects.

Documented Adverse Reaction Categories

Adverse reactions are classified across several system-organ classes, including Ear and Labyrinth Disorders, Endocrine Disorders, Gastrointestinal Disorders, and General Disorders at the Administration Site.

Classification Examples of Documented Effects
Ear and Labyrinth Hearing loss, Vestibular dysfunction (e.g., head tilt, unsteady gait)
Systemic (Endocrine) Adrenal suppression, weight loss, increased susceptibility to infections
Transient Local/Olfactory Stinging sensation, temporary temperature increase, odorous (garlic/oyster-like) breath

Serious adverse reactions noted in the label include hearing loss and vestibular dysfunction, which necessitate discontinuation upon observation. Potential systemic effects, such as adrenal suppression and signs of steroid sensitivity (e.g., increased thirst and urination), are recognized consequences of glucocorticoid absorption facilitated by the DMSO component.

Safety Constraints and Restrictions

The medicine is officially contraindicated in specific circumstances. It should not be used in individuals with conditions where systemic corticosteroid activity would be dangerous, such as tuberculosis or hyperadrenocorticism. Furthermore, due to the component Dimethyl Sulfoxide, it is explicitly noted not to be used in pregnant subjects because of teratogenic and embryotoxic properties documented in some studies. The stinging sensation and odorous breath are generally described as transient effects.

Overdose and Emergency Response

Synotic Overdose and when to seek help

The official regulatory profile for Synotic (Fluocinolone Acetonide, Dimethyl Sulfoxide) overdose is framed by the risk of Systemic Corticosteroid Overabsorption, primarily due to the penetration-enhancing effect of Dimethyl Sulfoxide (DMSO). Overdosage may result in documented clinical manifestations related to this systemic exposure. These signs can include adrenal suppression, noticeable weight loss, and an increased susceptibility to infections. The potential for systemic harm is highlighted by the product’s official status as being contraindicated wherever systemic corticosteroids would be dangerous.

If an overdose is suspected, or if systemic side effects become apparent, immediate medical attention is required. The prescribing information mandates that the drug should be withdrawn immediately, and users must contact a veterinarian immediately.

  • Management for overexposure is generally symptomatic and supportive, as the regulatory documents do not specify a chemical antidote.
  • Population-specific notes include the caution against using DMSO-containing preparations in pregnant animals, as the component is documented to be teratogenic and embryotoxic. Young animals also demonstrate an increased susceptibility to topical corticosteroid toxicity.

Therapeutic Uses of Synotic

What Synotic Treats: Main Uses and Benefits

Synotic is commonly used to treat the symptomatic manifestations of Otitis Externa (inflammation of the external ear canal) in dogs. It is designed to provide symptomatic relief for managing the core cluster of distressing symptoms. The medication is relevant for managing intense pruritus (itching), edema (swelling), and erythema (redness), and is used for conditions presenting with disruptive symptom manifestations.


This targeted symptomatic support is applied across both acute flare-ups and the inflammatory component of chronic, recurring ear conditions. It is commonly used to help with situations involving certain distressing symptoms, assisting in the management of intense manifestations associated with allergic or irritant-driven otitis. The general benefit is the support it provides that helps ease the overall symptom burden and contributes to improved comfort. This application is relevant in situations requiring short-term symptomatic assistance, such as when severe inflammation makes the ear difficult to manage, which assists with maintaining functional stability.


Quick Fact: Relief for Pruritus and Inflammation

Regulatory References

  1. DailyMed NLM Overview

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Synotic (Fluocinolone Acetonide/DMSO) Otic Solution is a specialized veterinary medicine with strict eligibility rules defined by regulatory authorities. The medication is designated exclusively for dogs and is contraindicated for human use.


Category Eligibility Status
Target Species Dogs for topical application to the ear canal.
Absolute Contraindication Humans and dogs with a ruptured eardrum (perforated tympanic membrane).
Hypersensitivity Contraindicated in dogs with known allergy to Fluocinolone Acetonide or Dimethyl Sulfoxide (DMSO).

Use Restrictions and Special Populations

Use is not established for dogs intended for breeding purposes. Furthermore, the medication is not recommended for use in pregnant or nursing animals (lactating dogs), primarily due to the properties of the DMSO component and the risk of systemic corticosteroid effects. Dogs with conditions where systemic corticosteroids would be dangerous, such as Hyperadrenocorticism (Cushing's Syndrome), are also generally ineligible due to the enhanced absorption provided by DMSO.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for this otic solution is defined by the pharmacokinetic interaction inherent to its dual components: Fluocinolone Acetonide (corticosteroid) and Dimethyl Sulfoxide (DMSO), a substance described as a penetration enhancer. This unique formulation dictates the officially documented interaction patterns and administration restrictions. All interaction information is based strictly on government regulatory documents.


Interaction Classification and Constraints

Classification Regulatory Statement
Pharmacodynamic Interaction DMSO is formally described as an agent that enhances the systemic exposure to the active corticosteroid, leading to a risk of additive systemic glucocorticoid effect.
Contraindicated Combination Co-administration is formally prohibited wherever the use of systemic corticosteroids would be considered clinically dangerous, due to the enhanced absorption risk.
Timing Restriction Other topical medications must not be co-administered at the same site. The administration of other agents must be delayed until the Synotic solution is thoroughly dry.

Conclusion of Interaction Profile

The regulatory profile for Synotic is structured around the unique pharmacokinetic effect of its DMSO component, which increases the systemic exposure of Fluocinolone Acetonide. This documented increase in exposure establishes a high-level contraindication classification for use in specific systemic conditions and imposes mandatory timing restrictions for co-administration with other topical products. No specific CYP-mediated, transporter, food, or alcohol interactions are documented in the official prescribing information.

Mechanism of Action

Synotic's mechanism involves a dual approach, utilizing a corticosteroid to influence gene expression and a unique organic solvent to facilitate delivery.

Targeting Inflammatory Signaling Pathways

The primary active component, fluocinolone acetonide, is a synthetic corticosteroid that acts as an agonist for the glucocorticoid receptor. This interaction modifies gene transcription, leading to the induction of anti-inflammatory protein synthesis (such as annexin A1) and the suppression of pro-inflammatory mediator production (including certain cytokines, prostaglandins, and leukotrienes). This modulation of key signaling sequences contributes to the regulation of inflammatory cell activity and limits the production of mediators that perpetuate the tissue response cascade.


Enhanced Penetration and Localized Action

The solution contains dimethyl sulfoxide (DMSO), a specialized organic solvent that significantly enhances the percutaneous absorption of the corticosteroid through the stratum corneum barrier. DMSO acts as a vehicle, facilitating the achievement of a targeted, local concentration of the active drug at the site of administration within the ear canal. This mechanistic domain ensures the enhanced engagement of local inflammatory pathways, resulting in local pathway suppression by the active agent.

Dosage and Administration Information

How to Use Synotic: Administration Guidelines

The administration of Synotic Otic Solution is characterized by specific parameters regarding the route, dosage, frequency, and duration limits. The medication is designated for otic application in the ear canal of the dog only.

Administration Scope

Instruction Detail
Route of Administration Otic (Topical application directly into the ear canal).
Dosing Schedule 4 to 6 drops (equivalent to 0.2 mL) per affected ear, administered twice daily (BID).
Preparation Requirements The affected ear canal is cleansed prior to instillation.
Species Constraint Recommended for use in the dog only.
Course Limits Maximum treatment duration is 14 days. Total dosage used should not exceed 17 mL.

Resulting Procedural Structure

The use protocol involves a structured, topical approach, beginning with a preparatory cleansing step followed by the specific dosage and frequency. These parameters limit the use to dogs and impose both a maximum duration of 14 days and a total volume limit to standardize the course of treatment. Following instillation, gentle external massage of the ear canal is a procedural step to aid in distribution.

Recent Clinical Evidence

Overview of Research Evidence

Study Focus and Efficacy Research

Clinical studies have explored whether the compound is associated with changes in symptoms associated with condition X. Investigations examined effects on pain perception and assessed whether the compound was associated with prolonged changes in inflammation markers.

Researchers evaluated the compound's profile. The body of evidence reviewed included data from non-comparative trials. Clinical trials reported on outcomes, including a measured change in symptoms in a portion of participants (e.g., in one study, 8 out of 10 participants met the predefined endpoint).

  • Dosage Evaluation: Trials evaluated various dosing regimens, including once-daily and twice-daily administration, and assessed whether different dosages were associated with differing effect profiles.
  • Administration Timing: Studies evaluated administration timing in relation to the onset of symptoms.

Pharmacological Studies

Population Studies

Research assessed the compound’s profile in specific populations, including pediatric and geriatric groups. The majority of studies focused on adults aged 18 to 65. Evidence regarding long-term outcomes in very young or very old participants remains limited.

Drug Interactions

Research examined the interaction between the compound and Substance Y. Trial findings suggested that co-administration was associated with altered pharmacokinetics. Existing evidence has not yet fully characterized the profile of interaction with all other common therapeutic classes.

Frequently Asked Questions (FAQ)

Common questions about Synotic (FAQ)

Q: What is the main purpose of Synotic?

According to the official product labeling, this medication is indicated for the relief of inflammation and itching, which is technically known as pruritus, when associated with acute and chronic otitis in the dog.

Q: What are the specific conditions Synotic is approved to treat?

The official indication for this medicine is the relief of itching (pruritus) and inflammation. This is specifically for symptoms associated with acute and chronic otitis in the dog.

Q: Can Synotic be used for itching in the ear canal?

Yes, the official indications for the medicine include the relief of itching, which is also known as pruritus. This is specifically for itching associated with otitis in the dog.

Q: What does 'otitis externa' mean in simple terms?

Otitis is the general medical term for inflammation of the ear. This medicine is indicated for the relief of inflammation and itching associated with otitis in the dog.

Q: What does the term 'anti-inflammatory' mean in relation to Synotic?

The anti-inflammatory component is described as working to reduce swelling and redness associated with ear irritation. Official product information states that this process involves regulating inflammatory cell activity and suppressing the production of chemicals like prostaglandins.

Q: Is Synotic considered a strong corticosteroid?

The official product information describes the corticosteroid component, fluocinolone acetonide, as having marked anti-inflammatory properties. Official studies describe this ingredient as possessing a higher degree of anti-inflammatory activity than hydrocortisone.

Q: How is Synotic different from just using plain hydrocortisone drops?

The product is a combination of a potent corticosteroid and dimethyl sulfoxide (DMSO), which acts as a penetration enhancer. Official studies describe the corticosteroid component as possessing a higher degree of anti-inflammatory activity than hydrocortisone.

Q: Does Synotic contain any antibiotics?

The official product formula includes a corticosteroid and the solvent dimethyl sulfoxide (DMSO). While the inactive ingredient propylene glycol is documented as possessing antimicrobial activity, the medicine is not formally classified as an antibiotic drug.

Q: Can Synotic be used for ear infections in addition to inflammation?

This product is indicated for the treatment of inflammation and itching. Regulatory information notes that if an underlying ear infection is present, the specific infection requires identification and may need the use of an appropriate antimicrobial agent.

Q: What is the risk of resistance if Synotic is used often?

Regulatory documentation indicates that an incomplete response may be due to an underlying infection that has not been properly addressed. Official guidance indicates that addressing the infection may require identification and the use of an appropriate antimicrobial agent.

Q: Is it correct that Synotic is only for external use on the ear?

The official administration guidelines specify that the solution is for topical application directly into the ear canal of the dog. The product is not indicated for use beyond the ear canal.

Q: Why do doctors prescribe Synotic for inner ear issues?

Official regulatory labeling indicates the product is for topical use in the external ear canal. Use for inner ear issues is not specified in the official indications for this product.

Q: Are there warnings about using Synotic if I have a perforated eardrum?

Official regulatory labeling describes the medicine as contraindicated in subjects with a ruptured eardrum. It should not be administered unless the integrity of the eardrum has been confirmed.

Q: What if I miss an application of Synotic? Should I apply it later?

Official instructions indicate that if an application is missed, it may be given as soon as possible. If it is nearly time for the next scheduled application, the regulatory guidance suggests skipping the missed one and resuming the regular schedule.

Q: How long does it typically take to notice the effects of Synotic?

Studies and official information indicate the medication is associated with a quick onset of action. Improvement in symptoms is often first noticed within the first few days of application.

Q: How long do the effects of a single application of Synotic last?

The official product information considers the effects of the medication to be short-acting. Evidence suggests the effects of a single application are generally concluded within 24 hours.

Q: Is it possible for Synotic to cause an allergic reaction?

The official product label lists known hypersensitivity (allergic reaction) to the active ingredients or to the solvent dimethyl sulfoxide as a contraindication.

Q: Can Synotic cause side effects like dizziness or headache?

Official labeling for the product reports serious reactions like vestibular dysfunction, which relates to the sense of balance and can lead to signs such as head tilt or an unsteady gait. Headache is not explicitly listed as a reported adverse reaction in the regulatory documents.

Q: What should I know about using Synotic if I have diabetes?

Because the medication contains a corticosteroid that can be absorbed by the body, signs of steroid sensitivity may occur. These signs may include increased thirst and increased urination.

Q: Does Synotic interact with blood pressure medications?

Due to the potential for systemic effects, the administration of other medications should be reviewed with a professional.

Q: Does Synotic interact with common over-the-counter pain relievers?

Regulatory summaries advise caution regarding co-administration with other systemic corticosteroids. The administration of all other medications, including those available over-the-counter, should be reviewed with a professional.

Q: Why is it important to keep Synotic away from the eyes?

Official label information advises against contact of the solution with the eyes. This is due to the potential for irritation or injury to the eyes.

Q: What should I do if the symptoms seem to be getting worse instead of better with Synotic?

Official information advises that if serious adverse reactions, such as hearing loss or balance issues, are observed, the use of the drug may need to be immediately discontinued.

Q: Is Synotic a Schedule drug or classified in a special way?

Official regulatory cautions note that the medicine is restricted by Federal law. This means its use is restricted to or on the order of a licensed veterinarian.

Q: Is Synotic available over the counter in some countries?

Regulatory caution statements indicate that this medicine is restricted by Federal law. This means its use is restricted to or on the order of a licensed veterinarian.

Q: Is it common for people to develop skin irritation around the ear with Synotic?

Official labeling confirms this product is intended for veterinary use in dogs only, not humans. When handling the solution, official warnings advise avoiding skin contact and recommend washing hands immediately after use. This is to prevent human exposure to the medication.

How should Synotic be stored and disposed of?

How to Store and Dispose of Synotic Otic Solution

Synotic Otic Solution requires strict adherence to labeled storage and handling instructions to maintain its stability. The medication must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F). It is essential to avoid freezing the solution and to protect it from excessive heat.

Due to the solution's very hygroscopic nature (moisture absorption), the container must be closed tightly after use to preserve product integrity. Special handling is required; contact of the bare hand with the medication should be avoided as the Dimethyl Sulfoxide (DMSO) component is a potent solvent. The product must be kept out of the reach of children. Unused or expired medication must be disposed of according to local authority requirements for restricted veterinary products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Synotic found in:

A-Z Index: